A nasal spray called esketamine may quickly and lastingly help people with severe depression that hasn’t responded to other treatments — and it might also reduce thoughts of suicide.
Claim Language
Language Strength
association
Uses association language (linked to, correlated with)
The claim uses the phrase 'is associated with,' which indicates a statistical or observational link rather than a direct cause-and-effect relationship. This language avoids claiming that esketamine causes the reduction, only that the two are linked.
Context Details
Domain
medicine
Population
human
Subject
Intranasal esketamine
Action
is associated with
Target
rapid onset and persistent reduction in depressive symptoms, including suicidal ideation
Intervention Details
Gold Standard Evidence Needed
According to GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this specific claim, ordered from strongest to weakest evidence.
Evidence from Studies
Supporting (1)
This study found that a nasal spray version of esketamine quickly and lastingly helps people with severe, hard-to-treat depression—especially those thinking about suicide—just like the claim says.